Mid-Morning Market Update: Markets Rise; Lennox Beats Q1 Views

Following the market opening Monday, the Dow traded up 0.22% to 34,117.37 while the NASDAQ rose 0.37% to 14,068.08. The S&P also rose, gaining 0.31% to 4,193.15.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,077,470 cases with around 572,200 deaths. India confirmed a total of at least 17,313,160 cases and 195,120 deaths, while Brazil reported over 14,340,780 COVID-19 cases with 390,790 deaths. In total, there were at least 147,238,540 cases of COVID-19 worldwide with more than 3,110,510 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Financial shares climbed by 1.3% on Monday. Meanwhile, top gainers in the sector included Jiayin Group Inc. JFIN, up 29%, and Atlantic Capital Bancshares, Inc. ACBI, up 7%.


In trading on Monday, consumer staples shares fell 0.9%.


Top Headline

Lennox International Inc. LII reported stronger-than-expected results for its first quarter.

Lennox reported quarterly earnings of $2.27 per share, beating analysts’ estimates of $1.31 per share. The company’s quarterly sales came in at $931.00 million, versus expectations of $790.95 million.

Lennox International raised FY21 adjusted EPS guidance from $10.55-$11.15 to $11.40-$12.00.
The company also raised sales growth guidance from 4-8% to 7-11%.


Equities Trading UP


Proofpoint, Inc. PFPT shares shot up 32% to $173.53. Private equity investment firm Thoma Bravo Advantage inked an agreement to acquire cybersecurity and compliance company Proofpoint in an all-cash transaction valuing Proofpoint at $12.3 billion.


Shares of Reviva Pharmaceuticals Holdings, Inc. RVPH got a boost, shooting 50% to $6.38 after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.


Casper Sleep Inc. CSPR shares were also up, gaining 26% to $8.85 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $10 to $10.50per share.

Check out these big movers of the day


Equities Trading DOWN

Sypris Solutions, Inc. SYPR shares tumbled 15% to $3.785 after jumping 59% on Friday.

Shares of Uxin Limited UXIN were down 14% to $1.8599. The company, last week, announced it entered a partnership with JD.com to "launch a self-operated online store for used car transactions through JD's platform."

Fortuna Silver Mines Inc. FSM was down, falling 13% to $6.71. Fortuna Silver Mines and Roxgold entered into a merger agreement.


Commodities


In commodity news, oil traded down 1.4% to $61.27, while gold traded up 0.1% to $1,779.40.


Silver traded up 0.1% Monday to $26.19 while copper rose 1.9% to $4.4160.


Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, the Spanish Ibex Index rose 0.5% and the German DAX 30 dropped 0.3%. Meanwhile, the French CAC 40 fell 0.1% London’s FTSE 100 fell 0.1% and Italy’s FTSE MIB gained 0.1%.

German Ifo Business Climate indicator increased slightly to 96.8 in April from the previous month's level of 96.6. Spain's producer price inflation increased to 6.3% year-over-year in March.


Economics


US durable goods orders rose 0.5% for March.


The Dallas Fed manufacturing index for April is scheduled for release at 10:30 a.m. ET.


The Treasury is set to auction 6-month bills and 2-year notes at 11:30 a.m. ET.


The Treasury will auction 3-month bills and 5-year notes at 1:00 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsBuilding ProductsIndustrialsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!